Literature DB >> 8510795

Effects of salsolinol on cultivated endothelial cells.

M F Melzig1, J Zipper.   

Abstract

In view of neurotoxic properties of tetrahydroisoquinolines (TIQ's) there are open questions also in regard to the disturbance of the blood-brain barrier. Because endothelial cells are an important element of this barrier the present study was designed to assess the influence of salsolinol (a TIQ formed by condensation of dopamine and acetaldehyde) on cultivated endothelial cells by physiological, biochemical and morphological investigations. For the investigations we used aortic endothelial cells because of a variety of similarities in physiology and biochemistry to brain capillary endothelial cells. Cytotoxic effects estimated by cell counting after 72 h treatment with salsolinol (IC50 = 38 mumol/l) were possibly caused by mitochondrial damages. Already after 2 h severe ultrastructural alterations of many mitochondria could be observed. The respiration activity of the cells was always inhibited after treatment with salsolinol for some hours. The damage of the mitochondria by salsolinol was not connected with inhibition of the activity of succinate dehydrogenase and cytochrome c + c1. Nevertheless the damages of mitochondrial integrity support the hypothesis that the neurotoxic effect of salsolinol is primarily caused by damaging the endothelial cells associated with a disturbance of blood-brain barrier.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8510795     DOI: 10.1007/BF00966783

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  9 in total

1.  [Is the estimation of the activity of MTT-reduction suitable for the determination of basal cytotoxicity?].

Authors:  M Melzig; U Dienwiebel
Journal:  Pharmazie       Date:  1990-07       Impact factor: 1.267

2.  Intracerebral microdialysis neurotoxicity studies of quinoline and isoquinoline derivatives related to MPTP/MPP+.

Authors:  R G Booth; N Castagnoli; H Rollema
Journal:  Neurosci Lett       Date:  1989-05-22       Impact factor: 3.046

3.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

Authors:  T Mosmann
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

4.  [The action of trypsin and zymosan on the respiration of cultivated endothelial cells].

Authors:  M Melzig; U Möller
Journal:  Pharmazie       Date:  1991-01       Impact factor: 1.267

5.  Metabolism and brain accumulation of tetrahydroisoquinoline (TIQ) a possible parkinsonism inducing substance, in an animal model of a poor debrisoquine metabolizer.

Authors:  S Ohta; O Tachikawa; Y Makino; Y Tasaki; M Hirobe
Journal:  Life Sci       Date:  1990       Impact factor: 5.037

6.  An endogenous substance of the brain, tetrahydroisoquinoline, produces parkinsonism in primates with decreased dopamine, tyrosine hydroxylase and biopterin in the nigrostriatal regions.

Authors:  T Nagatsu; M Yoshida
Journal:  Neurosci Lett       Date:  1988-04-22       Impact factor: 3.046

7.  Inhibition of mitochondrial respiration by 1,2,3,4-tetrahydroisoquinoline-like endogenous alkaloids in mouse brain.

Authors:  K Suzuki; Y Mizuno; M Yoshida
Journal:  Neurochem Res       Date:  1990-07       Impact factor: 3.996

8.  Inhibition of mitochondrial NADH-ubiquinone oxidoreductase activity and ATP synthesis by tetrahydroisoquinoline.

Authors:  K Suzuki; Y Mizuno; M Yoshida
Journal:  Neurosci Lett       Date:  1988-03-21       Impact factor: 3.046

Review 9.  Dopamine-derived alkaloids in alcoholism and in Parkinson's and Huntington's diseases.

Authors:  P Dostert; M Strolin Benedetti; G Dordain
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

  9 in total
  1 in total

Review 1.  Salsolinol: an Unintelligible and Double-Faced Molecule-Lessons Learned from In Vivo and In Vitro Experiments.

Authors:  Magdalena Kurnik-Łucka; Pertti Panula; Andrzej Bugajski; Krzysztof Gil
Journal:  Neurotox Res       Date:  2017-10-23       Impact factor: 3.911

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.